HEMOCHRON JR. CITRATE APTT CUVETTE J103C

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 2014-02-04 for HEMOCHRON JR. CITRATE APTT CUVETTE J103C manufactured by International Technidyne Corp..

Event Text Entries

[4432952] Healthcare professional reports results higher than reference laboratory with hemochron jr. Citrated aptt cuvette assay for pt with admitting diagnosis of abdominal pain and cholecystitis. Hemochron jr. Citrated aptt test generated result of 113 seconds, which was higher than the physician's expectations. Sample tested at the reference laboratory and result was 47. 5 seconds. Pt management was based on the laboratory result. No adverse event(s) reported.
Patient Sequence No: 1, Text Type: D, B5


[11844785] (b)(4).. Method: cuvette/single-use disposable. As part of itc's investigation, evaluation testing was performed on retain samples of a similar lot. Process evaluation performed. Review and trend analysis of finished product qc test data was performed. Manufacturing process reviewed. Result: an upward shift in non-heparinized blood response when compared to historical performance was identified. Conclusion: manufacturer notified fda on december 6, 2013 of the voluntary recall of (b)(4) lots of hemochron jr. Citrate aptt cuvettes. Itc's investigation into the product's performance identified that the affected lots of j103c cuvettes may recover higher than expected results in normal individuals. When testing non-heparinized (e. G. Normal blood samples), results may average higher than historic values. Test results performed on patients receiving heparin therapy are not affected. The upward shift in non-heparinized blood response is associated with a recent formulary optimization. Correction of the normal range shift being implemented to assure that test results from non-heparinized sampled in future lot releases will perform similar to historic experiences.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2248721-2014-00004
MDR Report Key3787201
Report Source06
Date Received2014-02-04
Date of Report2014-01-07
Date of Event2013-11-11
Date Mfgr Received2014-01-07
Device Manufacturer Date2013-05-01
Date Added to Maude2014-05-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactELEANOR FOX
Manufacturer Street20 CORPORATE PLACE SOUTH
Manufacturer CityPISCATAWAY NJ 08854
Manufacturer CountryUS
Manufacturer Postal08854
Manufacturer Phone7325485700
Manufacturer Street8 OLSEN AVE.
Manufacturer CityEDISON NJ 08820
Manufacturer CountryUS
Manufacturer Postal Code08820
Single Use3
Remedial ActionRC
Previous Use Code3
Removal Correction Number2250033-12/06/13-002
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON JR. CITRATE APTT CUVETTE
Product CodeGFO
Date Received2014-02-04
Catalog NumberJ103C
Lot NumberE3JCC014-P2
Device Expiration Date2014-05-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINTERNATIONAL TECHNIDYNE CORP.
Manufacturer AddressEDISON NJ 08820 US 08820


Patients

Patient NumberTreatmentOutcomeDate
10 2014-02-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.